Mark A. Kronenfeld, Director at Pacira Pharmaceuticals, Inc. (PCRX), sold 900 shares at $46.95 ($42K) on 2016-06-06, disclosed to the SEC on 2016-06-08.
Scheduled sale ($42k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PCRX | BUY | 2018-08-30 | $45K | — | Filing → |
| PCRX | BUY | 2017-11-13 | $42K | — | Filing → |
| PCRX | BUY | 2014-11-04 | $77K | — | Filing → |